Non-small Cell Lung Cancer, Indicated for anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC)
ALK-positive, locally advanced or metastatic NSCLC who have progressed on or are intolerant to crizotinib.
ALK-positive, locally advanced or metastatic NSCLC who have progressed on or are intolerant to crizotinib.
… Show more
Reviews
There are no reviews yet.